ニュース| APIメーカーとサプライヤー-Dr. Reddy's

2021

07/10/2021

The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021

2021

06/10/2021

Sugammadex Sodium API – CADIFA Approval by ANVISA

Deepak Sapra speaks about DRDO’s anti-covid drug 2DG

2021

27/05/2021

Deepak Sapra speaks about DRDO’s anti-covid drug 2DG

Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today

2021

27/05/2021

Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today

2021

21/01/2021

Best Supply Chain Team of the Year - Pharma- 2021

Dr. Reddy’s Laboratories’ Anil Patni presented on HPAPIs at Manufacturing Chemist Live Virtual

2020

10/11/2020

Dr. Reddy’s Laboratories’ Anil Patni presented on HPAPIs at Manufacturing Chemist Live Virtual

2020

03/11/2020

Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020

2020

19/10/2020

Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’

Dr. Reddy’s Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets

2020

05/10/2020

Dr. Reddy’s Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets

CPhI Festival of Pharma Panel discussion: Innovation Across Borders: How Pharma and innovators are fighting Back Against COVID-19 and ways forward.

2020

05/10/2020

CPhI Festival of Pharma Panel discussion: Innovation Across Borders: How Pharma and innovators are fighting Back Against COVID-19 and ways forward.

CPhI Festival of Pharma Roundtable: Tackling Nitrosamine Contamination

2020

13/10/2020

CPhI Festival of Pharma Roundtable: Tackling Nitrosamine Contamination

Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19

2020

01/07/2020

Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19

Dr. Reddy’s is featured in an article of Global Pharma Insights on “Nitrosamine contamination: pharma’s re-evaluation of its supply chain”

2020

01/04/2020

Dr. Reddy’s is featured in an article of Global Pharma Insights on “Nitrosamine contamination: pharma’s re-evaluation of its supply chain”

Dr. Reddy’s statement on the COVID-19 pandemic

2020

14/04/2020

Dr. Reddy’s statement on the COVID-19 pandemic

Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate

2020

01/04/2020

Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate

2020

01/03/2020

US DMF for Apalutamide - Now available

Dr. Reddy's Sustainability Report 2018-19

2020

01/03/2020

Dr. Reddy's Sustainability Report 2018-19

Dr. Reddy's API Team moves into its new office in China

2019

01/12/2019

Dr. Reddy's API Team moves into its new office in China

2019

01/11/2019

ニュース

The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021

Sugammadex Sodium API – CADIFA Approval by ANVISA

Deepak Sapra speaks about DRDO’s anti-covid drug 2DG

Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today

Best Supply Chain Team of the Year - Pharma- 2021

Dr. Reddy’s Laboratories’ Anil Patni presented on HPAPIs at Manufacturing Chemist Live Virtual

Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020

Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’

Dr. Reddy’s Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets

CPhI Festival of Pharma Panel discussion: Innovation Across Borders: How Pharma and innovators are fighting Back Against COVID-19 and ways forward.

CPhI Festival of Pharma Roundtable: Tackling Nitrosamine Contamination

Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19

Dr. Reddy’s is featured in an article of Global Pharma Insights on “Nitrosamine contamination: pharma’s re-evaluation of its supply chain”

Dr. Reddy’s statement on the COVID-19 pandemic

Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate

US DMF for Apalutamide - Now available

Dr. Reddy's Sustainability Report 2018-19

Dr. Reddy's API Team moves into its new office in China

Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2019